Delivery Order SPE2DB24D1205-SPE2DB25FCWYD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Feraheme 510 mg/17 ml vials valued at $7,744.26 with firm fixed pricing. This non-set-aside competitive award is scheduled for completion by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,262.01 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Feraheme 510 mg/17 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price delivery order, valued at $6,486.54, represents a non-competitive set-aside contract with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Feraheme is an intravenous iron replacement...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Feraheme 510 mg/17 ml vials with a ceiling value of $14,513.96. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a small-value pharmaceutical procurement supporting federal medical needs. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $3,299.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 25, 2025, with an ultimate completion date of September 26, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Feraheme (ferumoxytol) 510 mg/17 mL vials valued at $18,525.38 under a firm fixed-price arrangement. The award, made on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Feraheme 510 mg/17 mL vials. This non-set-aside, competitively awarded contract carries a ceiling value of $1,545.64 with firm fixed pricing and an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery...
- This is a $11,747.07 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a specialty pharmaceutical product used in the treatment of iron deficiency anemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a 510(mg)/17(mL) vial medication, with a ceiling value of $16,862.17 and a performance period extending to June 12, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $25,193.87, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Feraheme 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWYDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Feraheme 510 mg/17 mL vials. This contract, valued at $1,777.74 with a firm fixed price structure, represents a non-set-aside competitive award with an ultimate completion date of May 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for Feraheme, an iron replacement therapy medication, exemplifies AmerisourceBergen's role in fulfilling specialized pharmaceutical requirements across the Defense Health Agency and other government healthcare systems through the flexible IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/20/25 |